Beta Drugs

BETA
Price
-- --
 
Small Cap
₹2,320 Cr.
Beta Drugs, a part of the Adley Group, specializes in developing, manufacturing, and marketing oncology products like anti-cancer tablets, capsules, injections, and lyophilized injections. With a por… More
Beta Drugs, a part of the Adley Group, specializes in developing, manufacturing, and marketing oncology products like anti-cancer tablets, capsules, injections, and lyophilized injections. With a portfolio of over 50 products, the company serves both domestic and international customers from its manufacturing unit in Solan, Himachal Pradesh. Less
Beta Drugs, a part of the Adley Group, specializes in developing, manufacturing, and marketing onco… More
Beta Drugs, a part of the Adley Group, specializes in developing, manufacturing, and marketing oncology products like anti-cancer tablets, capsules, injections, and lyophilized injections. With a portfolio of over 50 products, the company serves both domestic and international customers from its manufacturing unit in Solan, Himachal Pradesh. Less
Low
990
52W Range
High
2,250
PE
55.94
Sector PE
30.46
P/B
9.48
Div.Yield
--
ROE
21.52%
EBIDTA
33.25
ROCE
20.66
EPS
8.93
WhatsApp

Get instant stock alerts
  • Share Price
  • Financials
  • Revenue mix
  • Shareholdings
  • Peers
  • Forensics
Niche index constructed using market cap and revenue exposure of companies in this sector

Coming soon

  • 5D
  • 1M
  • 6M
  • YTD
  • 1Y
  • 5Y
  • MAX

  • Summary

  • Profit & Loss

  • Balance sheet

  • Cashflow

Yearly | Quarterly
View Detailed Summary View Detailed Summary

This data is currently unavailable for this company.

Yearly | Quarterly
(In Cr.)
(In Cr.)

This data is currently unavailable for this company.
Financial Ratio's
(In %)
Detailed P&L Report Detailed P&L Report
(In Cr.)
Detailed Balance Sheet
Financial Year (In Cr.)
Detailed Cash Flow

  • Product wise

  • Location wise

BETA
Revenue Mix
    Latest
    |
    Historic

    This data is currently unavailable for this company.

    BETA
    Revenue Mix
    Latest
    |
    Historic

    This data is currently unavailable for this company.

    More Info

    Shareholdings

    Holders
    Detailed Shareholdings

    This data is currently unavailable for this company.

    Peers
    Detailed Peers

    Forensics

    View Detailed Forensics

    Recent events

    • News

    • Corporate Actions

    India's Beta Drugs jumps after regulatory milestones in Azerbaijan, Philippines
    Apr 22, 2026
    Beta Drugs To Buy 66.09% Of Nivian Life Sciences For 694 MLN Rupees
    Jan 09, 2026
    Beta Drugs Receives Dcgi Approval For Methotrexate Oral Solution
    Oct 16, 2025
    Beta Drugs To Consider Raising Of Funds
    Oct 16, 2024
    Beta Drugs To Write Off Investment Made Amounting $88,000 In Beta Ubk. International
    Nov 07, 2023
    Beta Drugs's Baddi Oncology Manufacturing Plant Receives ANVISA Approval
    Apr 20, 2023
    Events:
    Announcement Date
    May 14, 2026
    Announcement Date
    Nov 06, 2025
    Announcement Date
    May 15, 2025
    Bonus
    1 bonus shares for every 20 held. Bonus shares should be credited within 3 days after the ex-date.
    Ex Date
    Mar 26, 2025
    Announcement Date
    May 14, 2024
    Announcement Date
    Nov 07, 2023
    Announcement Date
    May 08, 2023
    Announcement Date
    Oct 27, 2022
    Announcement Date
    Apr 27, 2022
    Announcement Date
    Oct 25, 2021
    Announcement Date
    Apr 27, 2021
    Announcement Date
    Oct 19, 2020
    Announcement Date
    May 28, 2020

    More Small Cap Ideas

    See similar 'Small' cap companies with recent activity

    Promoter Buying

    Companies where the promoters are bullish

    Detailed List

    Capex

    Companies investing on expansion

    Detailed List

    Superstar Investor

    Companies where well known investors have invested

    Detailed List